When a pathogen — any organism that causes a disease — jumps species, scientists get nervous because its genetic makeup can reconfigure and become more transmissible or lethal.
Moderna gets $590M from US government
· 1d
Moderna Receives $590M From HHS to Develop Bird Flu Vaccine
HHS gives Moderna $590M to 'accelerate' bird flu vaccine trials
Bird Flu: US Invests $590 Million to Fast-Track Vaccine Development
The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.
The government is working to head off human bird flu infections. The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.
The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu strains, to ensure the United States is better prepared for future potential pandemics, according to a recent HHS news release.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.
This will also support the expansion of clinical studies for up to 5 more subtypes of pandemic influenza. Read more at straitstimes.com.
President Joe Biden's outgoing administration on Thursday announced $211 million in new funding to develop mRNA vaccines against emerging biothreats and said it was accelerating bird flu testing, as fears of another pandemic loom.
The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu vaccine.According to CNN, HSS on Friday, January 17, 2025, announced that it will award $590 million to Moderna to resume
HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.
Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 million to Moderna to develop vaccines to protect people from flu strains in bird
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback